Harry Karmouty-quintana
Assistant Professor
Department of Biochemistry And Molecular Biology
The University of Texas Health Science Center
United States of America
Biography
Dr. Harry Karmouty-Quintana has received his PhD in King's College London. Currently, he is working as Assistant Professor in University of Texas Medical School. He has received his postdoctoral fellowship McGill University, Canada.
Research Interest
Mechanisms of pulmonary hypertension (PH) associated with chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF); Mechanisms of adenosine signaling and hyaluronan that lead to PH in chronic lung diseases.
Publications
-
Karmouty-Quintana H, Siddiqui S, Hassan M, Tsuchiya K, Risse P-A, Xicota-Vila L, et al. Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure. AJP: Lung Cellular and Molecular Physiology [Internet]. American Physiological Society; 2012 Jan 27;302(8):L736–L745.
-
Karmouty-Quintana H, Zhong H, Acero L, Weng T, Melicoff E, West JD, et al. The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. The FASEB Journal [Internet]. FASEB; 2012 Mar 13;26(6):2546–57.
-
Karmouty-Quintana H, Xia Y, Blackburn MR. Adenosine signaling during acute and chronic disease states. Journal of Molecular Medicine [Internet]. Springer Nature; 2013 Jan 23;91(2):173–81.
-
Karmouty-Quintana H, Weng T, Garcia-Morales LJ, Chen N-Y, Pedroza M, Zhong H, et al. Adenosine A2B Receptor and Hyaluronan Modulate Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology [Internet]. American Thoracic Society; 2013 Dec;49(6):1038–47.
